122 related articles for article (PubMed ID: 2511711)
1. [The etiopathogenetic treatment of experimental tuberculosis using preparations with immunomodulating action].
Beliakova OI; Sibirnaia RI; Snitinskaia Os
Zh Mikrobiol Epidemiol Immunobiol; 1989 Sep; (9):70-4. PubMed ID: 2511711
[TBL] [Abstract][Full Text] [Related]
2. [Effect of experimental use of antitubercular preparations and various pathogenetic drugs on the immunological reactions of the body].
Beliakova OI; Kharakter ZhZ; Sibirnaia RI; Snitinskaia OS
Probl Tuberk; 1988; (4):65-8. PubMed ID: 3262223
[No Abstract] [Full Text] [Related]
3. [Effect of riboxine, levamisole and sodium oxybutyrate on the course of experimental tuberculosis].
Aleksandrova AE; Shcherbakova NM; Borisova LE; Zabolotnykh NV
Probl Tuberk; 1988; (3):56-60. PubMed ID: 3290889
[No Abstract] [Full Text] [Related]
4. [On the comparative effectiveness of rifampicin and INI treatment in guinea pigs inoculated with repeated microdoses of bacilli].
Fabbrocini V
Arch Tisiol Mal Appar Respir; 1968 Jun; 23(6):435-40. PubMed ID: 4984548
[No Abstract] [Full Text] [Related]
5. Influence of BCG-induced immunity on the bactericidal activity of isoniazid and rifampicin in experimental tuberculosis of the mouse and guinea-pig.
Dhillon J; Mitchison DA
Br J Exp Pathol; 1989 Feb; 70(1):103-10. PubMed ID: 2493801
[TBL] [Abstract][Full Text] [Related]
6. [Use of isoniazid with nitrofuran and 5-NHQ derivatives in experimental tuberculosis].
Il'ina TB; Vishnevskiĭ BI; Efremova IIa; Vavilin GI
Probl Tuberk; 1976; (8):51-5. PubMed ID: 826902
[No Abstract] [Full Text] [Related]
7. [Various indicators of the immunological response of the body after inclusion of pathogenetic agents in the chemotherapy of tuberculosis].
Sibirnaia RI; Beliakova OI
Probl Tuberk; 1984 Sep; (9):28-30. PubMed ID: 6334296
[No Abstract] [Full Text] [Related]
8. [Effect of levamisole on the immunological reactivity of mice infected with tuberculosis].
Chumak AA; Kostromin AP
Probl Tuberk; 1981 Oct; (10):58-62. PubMed ID: 7312855
[No Abstract] [Full Text] [Related]
9. The suitability of new drugs for intermittent chemotherapy of tuberculosis. An experimental study.
Dickinson JM
Scand J Respir Dis Suppl; 1969; 69():91-8. PubMed ID: 4190279
[No Abstract] [Full Text] [Related]
10. [Combined use of antitubercular drugs and metabolites of the tricarboxylic acid cycle in experimental tuberculosis].
Sokirko TA; Maliuk VI; Klimenko MT; Suslov EI
Probl Tuberk; 1990; (4):20-3. PubMed ID: 2395844
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol.
Dickinson JM; Mitchison DA
Tubercle; 1976 Dec; 57(4):251-8. PubMed ID: 827836
[TBL] [Abstract][Full Text] [Related]
12. [Levamisole treatment of experimental tuberculosis].
Aleksandrova AE; Zabolotnykh NV
Probl Tuberk; 1981 Oct; (10):55-8. PubMed ID: 7312854
[No Abstract] [Full Text] [Related]
13. [Molecular medicine and treatment of tuberculosis].
Perel'man MI; Khomiakov IuN; Kiselev VI; Severin ES; Pal'tsev MA
Probl Tuberk; 2001; (5):5-7. PubMed ID: 11588966
[No Abstract] [Full Text] [Related]
14. [New findings concerning the biochemical mechanisms of the tuberculous process and the correction of biochemical abnormalities using etiopathogenetic preparations].
Maliuk VI
Probl Tuberk; 1984 Nov; (11):61-4. PubMed ID: 6395132
[No Abstract] [Full Text] [Related]
15. [Effect of a number of therapeutic agents on immunity and nonspecific reactivity in respiratory viral infections in children].
Ivanova VV; Kurbatova GP; Aksenova OA; Blagoslovenskiĭ GS; Kamal'dinova EG
Pediatriia; 1985 Sep; (9):35-8. PubMed ID: 4080480
[No Abstract] [Full Text] [Related]
16. [Multiplication of Mycobacterium tuberculosis in the organs of mice with a single exposure to cyclophosphamide].
Vladimirskiĭ MA; Gordina AV; Dolzhanskiĭ VM
Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):67-70. PubMed ID: 6429986
[TBL] [Abstract][Full Text] [Related]
17. Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
Pandey R; Sharma A; Zahoor A; Sharma S; Khuller GK; Prasad B
J Antimicrob Chemother; 2003 Dec; 52(6):981-6. PubMed ID: 14613962
[TBL] [Abstract][Full Text] [Related]
18. The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.
Dickinson JM; Mitchison DA
Tidsskr Nor Laegeforen; 1975 Jun; 95(17-18):1087-9. PubMed ID: 806991
[No Abstract] [Full Text] [Related]
19. Bacteriologic basis of short-course chemotherapy for tuberculosis.
Grosset J
Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
[No Abstract] [Full Text] [Related]
20. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
